Keyword: Starboard Value

Activist investor Starboard Value is demonstrating its confidence in Parexel by disclosing a 5.7% stake buy in the company, immediately after news of the CRO’s potential $4 billion sale went out on the street.

Investor firm Starboard Value has posted a scathing public letter to the company demanding that its current board be stripped and replaced by 6 of its own choices.